- Home
- GHRS vs CABO Comparison
GHRS vs CABO Comparison
Compare GHRS & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- CABO
- Stock Information
- Founded
- GHRS 2018
- CABO 1980
- Country
- GHRS Ireland
- CABO United States
- Employees
- GHRS N/A
- CABO N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- CABO Cable & Other Pay Television Services
- Sector
- GHRS Health Care
- CABO Telecommunications
- Exchange
- GHRS Nasdaq
- CABO Nasdaq
- Market Cap
- GHRS 774.1M
- CABO 748.3M
- IPO Year
- GHRS 2021
- CABO N/A
- Fundamental
- Price
- GHRS $13.11
- CABO $152.17
- Analyst Decision
- GHRS Strong Buy
- CABO Hold
- Analyst Count
- GHRS 9
- CABO 3
- Target Price
- GHRS $29.33
- CABO $171.00
- AVG Volume (30 Days)
- GHRS 319.1K
- CABO 104.2K
- Earning Date
- GHRS 11-13-2025
- CABO 11-06-2025
- Dividend Yield
- GHRS N/A
- CABO 3.81%
- EPS Growth
- GHRS N/A
- CABO N/A
- EPS
- GHRS N/A
- CABO N/A
- Revenue
- GHRS N/A
- CABO $1,542,441,000.00
- Revenue This Year
- GHRS N/A
- CABO N/A
- Revenue Next Year
- GHRS N/A
- CABO N/A
- P/E Ratio
- GHRS N/A
- CABO N/A
- Revenue Growth
- GHRS N/A
- CABO N/A
- 52 Week Low
- GHRS $6.72
- CABO $117.54
- 52 Week High
- GHRS $20.50
- CABO $437.00
- Technical
- Relative Strength Index (RSI)
- GHRS 47.63
- CABO 39.32
- Support Level
- GHRS $12.26
- CABO $169.91
- Resistance Level
- GHRS $13.65
- CABO $180.00
- Average True Range (ATR)
- GHRS 0.75
- CABO 8.03
- MACD
- GHRS -0.08
- CABO -2.63
- Stochastic Oscillator
- GHRS 31.37
- CABO 0.00
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.